Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated

Technology appraisal guidance
Reference number: TA377
Published: 27 January 2016

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 172 KB)

Published:

05 July 2016

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 255 KB)

Published:

11 December 2015
Committee papers (PDF 653 KB)

Published:

11 December 2015

Appraisal consultation

Appraisal consultation
Appraisal consultation document (MSWord 88 KB)

Published:

11 June 2015
Committee papers information
Committee papers (PDF 7.27 MB)

Published:

11 June 2015

Final scope

Final scope (PDF 32 KB)

Published:

27 November 2014

Final matrix

Final matrix (PDF 34 KB)

Published:

27 November 2014

Comments table

Comments table (PDF 72 KB)

Published:

27 November 2014

Equality impact assessment - scoping

Equality impact assessment - scoping (PDF 16 KB)

Published:

27 November 2014

Draft scope for consultation (pre-referral) - October 2013

Draft scope for consultation (pre-referral) - October 2013 (PDF 107 KB)

Published:

26 March 2014

Provisional matrix (pre-referral) - October 2013

Provisional matrix (pre-referral) - October 2013 (PDF 101 KB)

Published:

26 March 2014